Prognozy (mln) dla Sino Biopharmaceutical Limited
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
31,051.71 |
35,148.52 |
38,968.07 |
43,166.04 |
45,186.57 |
51,140.23 |
| Przychód Δ r/r |
0.00% |
13.19% |
10.87% |
10.77% |
4.68% |
13.18% |
| Przychód (min) |
28,809.08 |
34,231.33 |
36,772.88 |
41,355.50 |
43,291.28 |
48,995.23 |
| Przychód (max) |
34,521.96 |
36,240.10 |
42,741.07 |
45,994.56 |
48,147.49 |
54,491.28 |
| EBITDA (średnia) |
10,937.79 |
12,140.88 |
13,460.21 |
14,910.26 |
15,608.19 |
17,664.68 |
| EBIT (średnia) |
13,863.60 |
10,616.33 |
11,769.99 |
13,037.96 |
13,648.24 |
15,446.50 |
| EBIT % |
44.65% |
30.20% |
30.20% |
30.20% |
30.20% |
30.20% |
| Zysk netto (średni) |
1,919.70 |
3,244.72 |
3,649.38 |
3,982.47 |
4,386.61 |
4,953.94 |
| Zysk netto % |
6.18% |
9.23% |
9.37% |
9.23% |
9.71% |
9.69% |
| EPS (średnia) |
0.15 |
0.19 |
0.21 |
0.23 |
0.24 |
0.27 |
| Liczba analityków (Przychody) |
22 |
23 |
23 |
19 |
8 |
10 |
| Liczba analityków (EPS) |
19 |
17 |
16 |
14 |
7 |
8 |
| symbol |
1177.HK |
1177.HK |
1177.HK |
1177.HK |
1177.HK |
1177.HK |